Serialized Carton Labeling (51662 1511 1 Serialized Carton Labeling 1014560 Adenosine Hf Label Image)
Adenosine Injection
Product Images NDC 51662-1511
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 51662-1511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Syringe (51662 1511 1 Syringe Labeling 25021 301 68 Adenosine Syr Label)
Syringe And Carton (51662 1511 1 Syringe And Box Labeling 25021 301 68 Adenosine Syr And Box Label)
Adverse Reactions (Adverse Reactions)
This appears to be a list of possible symptoms related to cardiovascular, respiratory, central nervous system, and gastrointestinal issues. These symptoms may include facial flushing, headache, shortness of breath, and nausea, among others. It is not clear what condition or context these symptoms are being listed for.*
How Supplied (How Supplied)
Adenosine Injection, USP is available in two different package factors, one is 6 mg per 2 mL in a 2 mL single-use prefilled plastic syringe and the other is 12 mg per 4 mL in a 4 mL single-use prefilled plastic syringe. Both package factors are available in a carton of 10 syringes each. The NDC codes for these are 25021-301-67 and 25021-301-68 respectively.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
